CONMED Corporation · 4 days ago
Sales Representative - Advanced Surgical - Central New Jersey
CONMED Corporation is seeking a Sales Representative to join their Advanced Surgical sales team. This role involves selling innovative technology in the OBGYN, Colorectal, Urology, and General Surgery fields while collaborating with healthcare professionals to improve patient outcomes.
Information TechnologyMedicalMedical Device
Responsibilities
Bring a high level of energy, drive, perseverance, commitment, and professionalism to achieve new sales and maintain existing business
Sell innovative technology to the OBGYN, Colorectal, Urology, and General Surgery spaces to positively impact patient outcomes
Receive extensive hands-on training
Ongoing collaboration and development from Field Sales Trainers
Earn the opportunity to grow and advance within the organization
Qualification
Required
Bachelor's degree + 2 years outside sales experience (Medical Device Preferred)
6+ years of outside sales, surgical tech, or related clinical experience required
Currently employed as a CONMED Associate Sales Representative
Approximately 20% travel
Must have a valid driver's license, clean driving record, and be able to drive an automobile
Meeting account requirements regarding vaccinations is required as an essential job function, including the COVID-19 vaccination
Benefits
Competitive compensation
Excellent healthcare including medical, dental, vision and prescription coverage
Short & long term disability plus life insurance -- cost paid fully by CONMED
Retirement Savings Plan (401K) -- CONMED matches your contributions dollar for dollar, with the potential for up to 7% per pay period
Employee Stock Purchase Plan -- allows stock purchases at discounted price
Tuition assistance for undergraduate and graduate level courses
Company
CONMED Corporation
CONMED is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients.
Funding
Current Stage
Public CompanyTotal Funding
$700M2022-05-31Post Ipo Debt· $700M
2012-07-16Acquired
2003-01-01Post Ipo Equity
Leadership Team
Recent News
2026-01-09
Yahoo Finance
2025-12-08
Company data provided by crunchbase